Melbourne researchers have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth.
The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia.
Dr Ben Shields and Dr Matt McCormack from the Walter and Eliza Hall Institute’s Cancer and Haematology division discovered that loss of the Hhex protein put the handbrake on leukaemia cell growth and division. The protein is a critical factor enabling AML cells to grow uncontrollably, a hallmark of cancer.
AML is an aggressive blood cancer that appears suddenly, grows quickly and has a poor prognosis. Existing treatments for AML are associated with serious side-effects. About three quarters of patients relapse after only a short period of treatment, with a five-year survival rate of just 24 per cent.
Dr McCormack said discovering how AML overcame normal cellular controls on growth and division was a breakthrough in the search for new therapies.
“There is an urgent need for new therapies to treat AML,” said Dr McCormack. “We showed blocking the Hhex protein could put the brakes on leukaemia growth and completely eliminate AML in preclinical models. This could be targeted by new drugs to treat AML in humans.”
He said Hhex was a particularly attractive therapeutic target because it was overproduced in leukaemia and, while essential for leukaemia cell growth, was not needed by healthy blood cells.
“Most existing treatments for AML are not cancer cell-specific, and unfortunately kill off healthy cells in the process,” Dr McCormack said.
“Hhex is only essential for the leukaemic cells, meaning we could target and treat leukaemia without toxic effects on normal cells, avoiding many of the serious side-effects that come with standard cancer treatments. We also know that most people with AML have increased levels of Hhex, often associated with adverse outcomes, further indicating it is an important target for new AML drugs.”
Dr Shields said AML cells switched off the controls that strictly manage cell growth and division. “Every cell has control genes that are activated when a cell is stressed, such as in the early stages of cancer, and stop the damaged cell from reproducing.” Dr Shields said.
While these control genes are still present in AML cells, they are switched off through a process called epigenetic modification. “Hhex works by recruiting epigenetic factors to growth control genes, effectively silencing them. This allows the leukaemia cells to reproduce and accumulate more damage, contributing to the speed of AML progression,” Dr Shields said.
Dr McCormack said drugs that inhibit epigenetic modification had been previously used to treat AML, but caused significant toxicity because their targets were also required for normal blood cell function.
“Unlike the epigenetic factors targeted previously, Hhex only regulates a small number of genes and is dispensable for normal blood cells. This gives us a rare opportunity to kill AML cells without causing many side effects,” said Dr McCormack. “We now hope to identify the critical regions of the Hhex protein that enable it to function, which will allow us to design much-needed new drugs to treat AML.”
The Latest on: Leukaemia
via Google News
The Latest on: Leukaemia
- BerGenBio Receives FDA Approval of Fast Track Designation for Bemcentinibon October 22, 2019 at 5:40 am
The company's proprietary lead candidate, bemcentinib, is a potentially first-in-class selective AXL inhibitor in a broad phase II oncology clinical development programme focused on combination and ...
- Family forced to rent $5,000-a-month Sydney apartment during boy's leukaemia treatmenton October 20, 2019 at 9:10 pm
"I'm incredibly annoyed it wasn't picked up earlier," Ms Gannon said. "And I'm very annoyed with the doctor that said to me that my son didn't have leukaemia, only to be told moments later by the ...
- Sinisa Mihajlovic faces his toughest fight as Bologna boss continues battle with leukaemiaon October 19, 2019 at 10:19 pm
A leopard doesn't change its spots after all. And so when the Serbian emotionally revealed he was fighting against leukaemia this summer, his players, peers and supporters knew this was just his ...
- Australia ace Christian Lealiifano overcame leukaemia at peak of his powers to make fairytale Rugby World Cup bowon October 19, 2019 at 2:15 am
A career nearing its summit was cruelly postponed by leukaemia three years ago - and was almost ended for good. Lealiifano was told he may never play rugby again when recovering slowly from the blood ...
- Bendigo Light the Night raises money for Leukaemia Foundationon October 18, 2019 at 4:08 am
Hundreds of people walked around Lake Weeroona at dusk on Friday in support of Light the Night. Hosted by the Bendigo Canoe Club, it raised funds for the Leukaemia Foundation. The event raised almost ...
- Antrim teen who beat leukaemia teams up with One Show's Matt Baker to raise money for Children In Needon October 16, 2019 at 11:37 am
A Co Antrim teenager who has recovered from an aggressive form of leukaemia — which took the life of her best friend — is preparing to travel 400 miles in a rickshaw for Children In Need. Adelle Keown ...
- Health-obsessed teacher who lived super-clean lifestyle killed by leukaemia at 33on October 16, 2019 at 6:53 am
Matt Meads avoided anything unhealthy in the hopes of living as long as possible (Picture: Kennedy News and Media) A health-obsessed teacher who avoided anything unhealthy in the hopes of living for ...
- Fit and healthy teacher dies 20 days after discovering he had leukaemia at 33on October 16, 2019 at 3:28 am
He was fit and healthy, and avoided drinking and smoking. Matt died only 20 days after a shock leukaemia diagnosis - aged just 33Credit: Kennedy News and Media But just three weeks after first falling ...
- Gym-addict tee-total teacher, 33, dies just 20 days after shock leukaemia diagnosison October 16, 2019 at 3:03 am
A fitness-obsessed primary school teacher whose lifestyle revolved around trying to live as long as possible died just 20 days after a bombshell leukaemia diagnosis. Matt Meads, 33, coupled regular ...
- Leukaemia Therapeutics Market, Market Share, News, Demand And Opportunity during 2016-2022on October 16, 2019 at 12:44 am
Oct 16, 2019 (AmericaNewsHour) -- Leukaemia is the cancer of blood cells. Blood cells originate from HSCs, hematopoietic stem cells, in the bone marrow. Thereafter they undergo maturation process ...
via Bing News